Zhang Yan, Yu Bo, Han Yaling, Wang Jianan, Yang Lixia, Wan Zheng, Zhang Zheng, Chen Yuguo, Fu Xianghua, Gao Chuanyu, Li Bao, Chen Jiyan, Wu Ming, Ma Yitong, Zhao Xingsheng, Chen Yundai, Yan Hongbing, Xiang Dingcheng, Fang Weiyi, Mehta Sameer, Naber Christoph K, Ge Junbo, Huo Yong
Department of Cardiology, Peking University First Hospital, Beijing, China.
Cardiology, Key Laboratories of Education Ministry for Myocardial Ischemia Mechanism and Treatment, 2nd Affiliated Hospital of Harbin Medical University, Harbin, China.
BMJ Open. 2019 Jul 17;9(7):e026362. doi: 10.1136/bmjopen-2018-026362.
Successful ST-segment elevation myocardial infarction (STEMI) management is time-sensitive and is based on prompt reperfusion mainly to reduce patient mortality. It has evolved from a single hospital care to an integrated regional network approach over the last decades. This prospective study, named the China STEMI Care Project (CSCAP), aims to show how implementation of different types of integrated regional STEMI care networks can improve the reperfusion treatment rate, shorten the total duration of myocardial ischaemia and lead to mortality reduction step by step.
The CSCAP is a prospective, multicentre registry study of three phases. A total of 18 provinces, 4 municipalities and 2 autonomous regions in China were included. Patients who meet the third universal definition of myocardial infarction and the Chinese STEMI diagnosis and treatment guidelines are enrolled. Phase 1 (CSCAP-1) focuses on the in-hospital process optimisation of primary percutaneous coronary intervention (PPCI) hospitals, phase 2 (CSCAP-2) focuses on the PPCI hospital-based regional STEMI care network construction together with emergency medical services and adjacent non-PPCI hospitals, while phase 3 (CSCAP-3) focuses on the whole-city STEMI care network construction by promoting chest pain centre accreditation. Systematic data collection, key performance index assessment and subsequent improvement are implemented throughout the project to continuously improve the quality of STEMI care.
The study has been reviewed and approved by the Ethics Committee of Peking University First Hospital. Ranking reports of quality of care will be generated available to all participant affiliations. Results will be disseminated via peer-reviewed scientific journals and presentations at congresses.
NCT03821012.
成功管理ST段抬高型心肌梗死(STEMI)对时间要求严格,主要基于迅速再灌注以降低患者死亡率。在过去几十年中,其已从单一医院治疗模式演变为综合区域网络模式。这项名为中国STEMI关爱项目(CSCAP)的前瞻性研究旨在展示不同类型的综合区域STEMI关爱网络的实施如何逐步提高再灌注治疗率、缩短心肌缺血总时长并降低死亡率。
CSCAP是一项分三个阶段的前瞻性多中心注册研究。研究纳入了中国18个省、4个直辖市和2个自治区。纳入符合心肌梗死第三次通用定义及中国STEMI诊断与治疗指南的患者。第一阶段(CSCAP-1)聚焦于主要经皮冠状动脉介入治疗(PPCI)医院的院内流程优化,第二阶段(CSCAP-2)聚焦于以PPCI医院为基础,联合急救医疗服务及相邻非PPCI医院构建区域STEMI关爱网络,而第三阶段(CSCAP-3)则通过推动胸痛中心认证聚焦于全市STEMI关爱网络建设。在整个项目中实施系统的数据收集、关键绩效指标评估及后续改进,以持续提高STEMI治疗质量。
本研究已通过北京大学第一医院伦理委员会的审查与批准。将生成护理质量排名报告供所有参与单位使用。研究结果将通过同行评议的科学期刊及在大会上的报告进行传播。
NCT03821012。